Duff & Phelps Investment Management CO Abb Vie Inc. Transaction History

Duff & Phelps Investment Management CO

$8.58 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $2.53 Million - $2.95 Million	-16,318 Reduced 80.12%	4,049 $694,000
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $120,823 - $137,667	756 Added 3.85%	20,367 $3.71 Million
Q4 2023 Feb 05, 2024	BUY	$137.6 - $154.97 $13,760 - $15,497	100 Added 0.51%	19,611 $3.04 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $21,641 - $25,053	162 Added 0.84%	19,511 $2.91 Million
Q2 2023 Aug 03, 2023	BUY	$132.51 - $164.9 $19,876 - $24,735	150 Added 0.78%	19,349 $2.61 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $43,383 - $49,962	300 Added 1.59%	19,199 $3.06 Million
Q1 2022 May 11, 2022	BUY	$131.98 - $163.75 $27,715 - $34,387	210 Added 1.12%	18,899 $3.06 Million
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $15,147 - $19,166	141 Added 0.76%	18,689 $2.53 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $44,475 - $50,486	-418 Reduced 2.2%	18,548 $2 Million
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $179,383 - $199,843	-1,705 Reduced 8.25%	18,966 $2.14 Million
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $27,621 - $30,407	-270 Reduced 1.29%	20,671 $2.24 Million
Q4 2020 Jan 29, 2021	BUY	$80.49 - $108.67 $16,097 - $21,734	200 Added 0.96%	20,941 $2.24 Million
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $280,346 - $375,145	3,821 Added 22.58%	20,741 $2.04 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $25,155 - $38,138	390 Added 2.36%	16,920 $1.29 Million
Q4 2019 Jan 24, 2020	BUY	$72.13 - $90.25 $21,639 - $27,075	300 Added 1.85%	16,530 $1.46 Million
Q2 2019 Aug 02, 2019	BUY	$65.7 - $83.98 $11,169 - $14,276	170 Added 1.06%	16,230 $1.18 Million
Q3 2018 Oct 22, 2018	SELL	$88.91 - $98.84 $57,791 - $64,246	-650 Reduced 3.89%	16,060 $1.52 Million
Q2 2018 Aug 02, 2018	SELL	$89.78 - $106.23 $40,401 - $47,803	-450 Reduced 2.62%	16,710 $1.55 Million
Q1 2018 May 01, 2018	SELL	$92.01 - $123.21 $41,404 - $55,444	-450 Reduced 2.56%	17,160 $1.62 Million
Q4 2017 Jan 24, 2018	SELL	$89.56 - $98.21 $28,659 - $31,427	-320 Reduced 1.78%	17,610 $1.7 Million
Q3 2017 Oct 25, 2017	BUY	$69.85 - $89.22 $1.25 Million - $1.6 Million	17,930	17,930 $1.59 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Duff & Phelps Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Duff & Phelps Investment Management CO with notifications on news.

Account